Goldenwell Biotech, Inc. engages in the nutraceutical and dietary supplements business. It offers JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement. The company was incorporated in 2019 and is based in Solon, Ohio.
Frequently asked questions
What sector does Goldenwell Biotech Inc (GWLL) operate in?
Goldenwell Biotech Inc belongs to the Consumer Staples sector and operates in the Packaged Foods industry.
What is Goldenwell Biotech Inc (GWLL) current stock price?
As of the latest data, Goldenwell Biotech Inc stock price is $0.65, with a previous close of $0.65.
What is Goldenwell Biotech Inc (GWLL) current market capitalization?
Goldenwell Biotech Inc market cap is approximately 64.35 million.
What is Goldenwell Biotech Inc (GWLL) EBITDA?
Goldenwell Biotech Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -34.78 thousand.
Does Goldenwell Biotech Inc (GWLL) pay dividends?
No. Goldenwell Biotech Inc does not pay a dividend.
What is Goldenwell Biotech Inc (GWLL) beta (volatility) score?
Goldenwell Biotech Inc has a beta of 4.814, indicating very high volatility compared to the market.